A detailed history of Kempner Capital Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Kempner Capital Management Inc. holds 87,901 shares of PFE stock, worth $2.46 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
87,901
Holding current value
$2.46 Million
% of portfolio
1.35%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$25.89 - $29.73 $2.28 Million - $2.61 Million
87,901 New
87,901 $2.44 Million
Q3 2021

Nov 01, 2021

SELL
$39.25 - $50.42 $1.29 Million - $1.66 Million
-32,950 Closed
0 $0
Q4 2020

Jan 05, 2021

SELL
$33.47 - $42.56 $998,577 - $1.27 Million
-29,835 Reduced 47.52%
32,950 $1.21 Million
Q2 2020

Jul 15, 2020

SELL
$30.12 - $36.54 $4,397 - $5,334
-146 Reduced 0.23%
62,785 $2.05 Million
Q1 2020

Apr 13, 2020

BUY
$27.03 - $38.62 $987,405 - $1.41 Million
36,530 Added 138.37%
62,931 $2.05 Million
Q4 2019

Jan 14, 2020

SELL
$32.92 - $37.36 $1,678 - $1,905
-51 Reduced 0.19%
26,401 $1.03 Million
Q1 2019

Apr 05, 2019

SELL
$37.5 - $41.2 $112 - $123
-3 Reduced 0.01%
26,452 $1.12 Million
Q3 2018

Oct 05, 2018

SELL
$34.47 - $41.81 $1.05 Million - $1.28 Million
-30,527 Reduced 53.57%
26,455 $1.17 Million
Q2 2018

Jul 09, 2018

SELL
$32.98 - $35.16 $692 - $738
-21 Reduced 0.04%
56,982 $2.07 Million
Q1 2018

Apr 06, 2018

BUY
$31.91 - $37.02 $6,988 - $8,107
219 Added 0.39%
57,003 $2.02 Million
Q4 2017

Jan 09, 2018

SELL
$33.26 - $35.29 $17,927 - $19,021
-539 Reduced 0.94%
56,784 $2.06 Million
Q3 2017

Oct 10, 2017

BUY
$31.0 - $34.15 $1.78 Million - $1.96 Million
57,323
57,323 $2.05 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kempner Capital Management Inc. Portfolio

Follow Kempner Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kempner Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kempner Capital Management Inc. with notifications on news.